Marco Investment Management LLC raised its stake in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 100.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 6,450 shares of the company’s stock after purchasing an additional 3,225 shares during […]
Marco Investment Management LLC lifted its holdings in Novo Nordisk A/S (NYSE:NVO – Free Report) by 100.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,450 shares of the company’s stock after buying an additional 3,225 shares during the quarter. Marco Investment […]
Marco Investment Management LLC increased its position in shares of Novo Nordisk A/S (NYSE:NVO – Free Report) by 100.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,450 shares of the company’s stock after purchasing an additional […]
Oppenheimer Asset Management Inc. raised its position in Novo Nordisk A/S (NYSE:NVO – Free Report) by 153.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 395,248 shares of the company’s stock after purchasing an additional 239,042 shares during the period. Oppenheimer Asset Management Inc.’s […]
Shares of Novo Nordisk A/S (NYSE:NVO – Get Free Report) have received a consensus rating of “Moderate Buy” from the eight analysts that are currently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12 […]